Affimed N.V. (AFMD): Price and Financial Metrics
AFMD Price/Volume Stats
| Current price | $0.90 | 52-week high | $8.95 |
| Prev. close | $0.88 | 52-week low | $0.85 |
| Day low | $0.87 | Volume | 47,968 |
| Day high | $0.98 | Avg. volume | 154,347 |
| 50-day MA | $1.05 | Dividend yield | N/A |
| 200-day MA | $3.23 | Market Cap | 14.49M |
AFMD Stock Price Chart Interactive Chart >
Affimed N.V. (AFMD) Company Bio
Affimed NV is a clinical-stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies. The company was founded in 2000 and is based in Heidelberg, Germany.
AFMD Price Returns
| 1-mo | -15.09% |
| 3-mo | -40.40% |
| 6-mo | -77.61% |
| 1-year | -80.31% |
| 3-year | -97.90% |
| 5-year | -93.92% |
| YTD | -24.37% |
| 2024 | -80.96% |
| 2023 | -49.60% |
| 2022 | -77.54% |
| 2021 | -5.15% |
| 2020 | 112.41% |
Continue Researching AFMD
Want to see what other sources are saying about Affimed NV's financials and stock price? Try the links below:Affimed NV (AFMD) Stock Price | Nasdaq
Affimed NV (AFMD) Stock Quote, History and News - Yahoo Finance
Affimed NV (AFMD) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...